Hypofractionated palliative radiotherapy (17 Gy per two fractions) in advanced non-small-cell lung carcinoma is comparable to standard fractionation for symptom control and survival: A national phase III trial

Journal of Clinical Oncology

Volumn 22, Issue 5, 2004, Pages 801-810

  Sundstrøm, Stein ^a   Bremnes, Roy ^a   Aasebø, Ulf ^a   Aamdal, Steinar ^a   Hatlevoll, Reidulv ^a   Brunsvig, Paal ^a   Johannessen, Dag Clement ^a   Klepp, Olbjørn ^a   Fayers, Peter M ^a   Kaasa, Stein ^a  

^a TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER PALLIATIVE THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MEDICAL ASSESSMENT; PATIENT COMPLIANCE; PATIENT SELECTION; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; QUESTIONNAIRE; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE; SURVIVAL TIME; AGED; COMPARATIVE STUDY; FEMALE; LUNG TUMOR; MALE; METHODOLOGY; MIDDLE AGED; MORTALITY; NONPARAMETRIC TEST; PALLIATIVE THERAPY; PATHOLOGY; PHASE 3 CLINICAL TRIAL; PROBABILITY; RADIATION RESPONSE; RADIOTHERAPY; REFERENCE VALUE; RISK ASSESSMENT; STANDARD; SURVIVAL; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; DOSE FRACTIONATION; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PALLIATIVE CARE; PROBABILITY; PROGNOSIS; QUALITY OF LIFE; RADIOTHERAPY; RADIOTHERAPY DOSAGE; REFERENCE VALUES; RISK ASSESSMENT; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 1542713367     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2004.06.123     Document Type: Article

References (29)

1. Simpson JR, Francis ME, Perez-Tamayo R, et al: Palliative radiotherapy for inoperable carcinoma of the lung: Final Report of a RTOG multi-institutional trial. Int J Radiat Oncol Biol Phys 11:751-758, 1985
2. Collins TM, Ash DV, Close HJ, et al: An evaluation of the palliative role of radiotherapy in inoperable carcinoma of the bronchus. Clin Radiol 39:284-286, 1988
3. Langendijk JA, Ten Velde GPM, Aaronson NK, et al: Quality of life after palliative radiotherapy in non-small cell lung cancer: A prospective study. Int J Radiat Oncol Biol Phys 1:149-155, 2000
4. MRC Lung Cancer Working Party, Bleehan NM, Girling DJ, et al: Inoperable non-small-cell lung cancer (NSCLC): A Medical Research Council (MRC) randomised trial of palliative radiotherapy with two fractions or ten fractions. Br J Cancer 63:265-270, 1991
5. MRC Lung Cancer Working Party, Bleehan NM, Girling DJ, et al: A Medical Research Council (MRC) randomised trial of palliative radiotherapy with two fractions or a single fraction in patients with inoperable non-small-cell lung cancer (NSCLC) and poor performance status. Br J Cancer 65:934-941, 1992
6. Rees GJ, Devrell CE, Barley VL, et al: Palliative radiotherapy for lung cancer: two versus five fractions. Clin Oncol (R Coll Radiol) 9:90-95, 1997
7. Abratt RP, Shepard LJ, Mameena Salton DG: Palliative radiation for stage 3 non-small cell lung cancer: A prospective study of two moderately high dose regimens. Lung Cancer 13:137-143, 1995
8. Teo P, Tai H, Choy D, et al: A randomised study on palliative radiation therapy for inoperable non small cell carcinoma of the lung. Int J Radiat Oncol Biol Phys 14:867-871, 1988
9. Macbeth FR, Bolger JJ, Hopwood P, et al: Randomized trial of palliative two-fraction versus more intensive 13-fraction radiotherapy for patients with inoperable non-small cell lung cancer and good performance status. Medical Research Council Lung Cancer Working Party. Clin Oncol (R Coll Radiol) 8:167-175, 1996
10. Reinfuss M, Glinski B, Kowalska T, et al: Radiothérapie du cancer bronchique non à petite cellules de stade III, inopérable, asymptomatique: Résultats définitifs d'un essai prospectif randomisé (240 patients). Cancer Radiother 3:475-479, 1999
11. Bezjak A, Dixon P, Brundage M, et al: Randomized phase III trial of single versus fractionated thoracic radiation in the palliation of patients with lung cancer (NCIC CTG SC.15). Int J Radiat Oncol Biol Phys 54:719-728, 2002
12. Kaasa S: Measurement of quality of life in clinical trials. Oncology 49:288-294, 1992
13. Finlay IG, Dunlop R: Quality of life assessment in palliative care. Ann Oncol 5:13-18, 1994
14. Kaasa S, Mastekaasa A, Naess S: Quality of life of lung cancer patients in a randomized clinical trial evaluated by a psychosocial well-being questionnaire. Acta Oncol 27:335-342, 1988
15. World Health Organization. Histological Typing of Lung and Pleural Tumours (ed 3). Geneva, Switzerland, Springer-Verlag, 1999
16. Mountain CF: A new international staging system for lung cancer. Chest 89:2255-2333, 1986 (suppl 4)
17. Kirk J, Gray WM, Watson ER: Cumulative radiation effect: Part I. Fractionated treatment regimes. Clin Radiol 22:145-155, 1971
18. Aaronson NK, Ahmedzai S, Bergmann B, et al: The European Organization for Research and Treatment of Cancer QLQ-C-30: A quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365-376, 1993
19. Bergmann B, Aaronson NK, Ahmedzai S, et al: The EORTC QLQ-LC13: A modular supplement to the EORTC Core Quality of Life Questionnaire (QLQ-C30) for use in lung cancer clinical trials - EORTC Study Group on Quality of Life. Eur J Cancer 30A:635-642, 1994
20. Fayers PM, Aaronson N, Bjordal K, et al: EORTC QLQ-C30 Scoring Manual. Brussels, Belgium, EORTC Quality of Life Study Group, 1995
21. Osoba D, Rodrigues G, Myles J, et al: Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol 16:139-144, 1988
22. King MT: Interpreting of scores from the EORTC quality of life questionnaire QLQ-C30. Qual Life Res 5:555-567, 1996
23. Carbone DP, Minna JD: Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomized clinical trials. Non-Small Cell Lung Cancer Collaboration Group: BMJ 311:899-909, 1995
24. Helsing M, Bergman B, Thaning L, et al: Quality of life and survival in patients with advanced non-small cell lung cancer receiving supportive care plus chemotherapy with carboplatin and etoposide or supportive care only: A multi-centre randomised phase III trial. Eur J Cancer 34:1036-1044, 1998
25. Socinski MA, Morris DE, Masters GA, et al: Chemotherapeutic management of stage IV non-small cell lung cancer. Chest 123:226S-243S, 2003 (suppl 1)
26. Macbeth F, Toy E, Coles B, et al: Palliative radiotherapy regimens for non-small cell lung cancer. Cochrane Database Syst Rev 1:CD002143, 2002
27. Maher EJ, Coia L, Duncan G, et al: Treatment strategies in advanced and metastatic cancer: Difference in attitude between the USA, Canada and Europe. Int J Radiat Oncol Biol Phys 23:239-244, 1992
28. Macbeth FR, Wheldon TE, Girling DJ, et al: Radiation myelopathy: Estimates of risk in 1048 patients in three randomized trials of palliative radiotherapy for non-small cell lung cancer. The Medical Research Council Lung Cancer Working Party. Clin Oncol (R Coll Radiol) 8:176-181, 1996
29. Dardoufas C, Plataniotis GA, Damatopoulou A, et al: A case of radiation myelopathy after 2 x 8 5 Gy for inoperable non-small cell lung cancer. Eur J Cancer 31A:2418-2419, 1995